Welcome to ATMP Sweden!
ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
The ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu. Other Swedish ATMP specific national networks within the ATMP Sweden umbrella include NextGenNK focused on cost effective development of Natural Killer (NK) cell based therapies and SWECARNET, Sweden’s network for clinical use of CAR T cells.
Driving ATMP technological developments, research translation and manufacturing capabilities.
Work with us towards making Sweden a world leader in advanced therapies by 2030.
Competence Center for the development of next generation NK cell-based cancer immunotherapies.
Conferences & events
Conference
ATMP Sweden Virtual 2021
16 November
Online
Organizer: ATMP Sweden
How are 'gene delivery' COVID vaccines relevant to ATMP solutions?
Read moreCourse
INTRODUCTION TO ATMP COURSE
22 November
Online
Organizer: ATMP Innovation Milieu
AVAILABLE from the 9th of June 2021! Learn the basics of Advanced Therapy Medicinal Products.
Read moreResearch & development
Learn more about the Health Technology Assessment related issues of your ATMP development.
This guide will provide useful information and insights throughout the ATMP development process.
Find or advertise ATMP relevant job opportunities.
What are ATMPs?
News
2021-07-29
Sahlgrenska progresses TILs manufacturing for clinical trials
An important step for patients with metastatic uveal melanoma.
Read article
2021-06-28
ATMP Sweden newsletter June 2021
Including launch of our ATMP Introductory course!
Read article